– First regimen to be approved in China to demonstrate superiority to platinum-containing chemotherapy for the treatment of locally advanced or metastatic urothelial cancer, the standard of care for nearly 40 years1 – NMPA approval based on the global Phase 3 EV-302 trial (also known as…